Breo Ellipta vs Xolair
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Breo Ellipta | US Xolair |
|---|---|---|
| Generic name | fluticasone furoate/vilanterol Unverified catalogue summary (Generic name) for Breo Ellipta in US; not checked against current local product information. | omalizumab Unverified catalogue summary (Generic name) for Xolair in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Breo Ellipta in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Xolair in US; not checked against current local product information. |
| Treats | Asthma, COPD Unverified catalogue summary (Treats) for Breo Ellipta in US; not checked against current local product information. | Allergic asthma, chronic spontaneous urticaria and IgE-mediated food allergy Unverified catalogue summary (Treats) for Xolair in US; not checked against current local product information. |
| Category | Respiratory Unverified catalogue summary (Category) for Breo Ellipta in US; not checked against current local product information. | Respiratory Unverified catalogue summary (Category) for Xolair in US; not checked against current local product information. |
| Manufacturer | GSK Unverified catalogue summary (Manufacturer) for Breo Ellipta in US; not checked against current local product information. | Genentech, Inc. Unverified catalogue summary (Manufacturer) for Xolair in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Breo Ellipta in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Xolair in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Breo Ellipta in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Xolair in US; not checked against current local product information. |
| Est. TV ad spend | $100M | $95M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Breo Ellipta in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Xolair in US; not checked against current local product information. |
Breo Ellipta
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Breo Ellipta or Xolair better?
This directory does not compare clinical effectiveness or safety. Listing Breo Ellipta and Xolair together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Breo Ellipta and Xolair?
The table shows catalogue identification and estimated advertising information for Breo Ellipta and Xolair, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Breo Ellipta has the larger estimated TV advertising budget of the two.